Non-cultured epidermal cell suspension (NCECS) is a relatively new cellular grafting technique for vitiligo. Platelet rich fibrin (PRF) is a platelet and immune concentrate gather on a single fibrin membrane which can be used in conjunction with grafts and has several advantages, such as promoting wound healing, haemostasis, and give better handling properties to graft materials. This study was conducted to determine the efficacy of NCECS combined with PRF in patients with stable vitiligo. Seven patients with stable vitiligo which not responding to topical and phototherapy for more than 12 months were included in the study. The melanocytes were harvested as an autologous melanocyte rich suspension from a donor skin. The non cultured melanocyte transplanted to recipient area that had been superficially dermabraded and smeared with PRF gel. Of all 7 patients, 1 patients showed excellent pigmentation (90-100%), 2 had good repigmentation (60-89%), 1 had fair repigmentation (25-59%) and 3 patients had a poor response (0-24%). The procedure is safe and promising surgical modality for stable vitiligo.
Exogenous ochronosis (EO) is a rare, cosmetically disfiguring condition, resulting from the long term use of topical hydroquinone in treatment of melasma. The studies about it are small and many of the treatments have mixed result. Autologous human platelet rich fibrin (PRF-L) is contains platelet that are purpose to release numerous growth factor that valuable in numerous dermatologic application.Platelet rich fibrin lysate used for EO has not been reported. We presented three cases with EO treated with split-face of the PRF-L applied right before dermaroller on right face and intradermal injection on the left for 8 weeks.The treatment re-apply every 2 weeks. The improvement was measuring by 10-point grading scale and dermoscopic examination, including five-point grading scale to assessment of patient satisfaction. All of three patients demonstrated significant improvementand very satisfied in 4th week of treatment. This result suggests that PRF-L can be used as of one modality for EO treatment.
<p>Herpes simplex virus (HSV) adalah penyebab herpes genitalis (HG). Perubahan imunologi saat kehamilan akan meningkatkan kerentanan terhadap infeksi HSV yang merupakan penyebab morbiditas dan mortalitas ibu dan janin. Pengaruh infeksi ini pada ibu dan janin/neonatus tergantung apakah infeksi primer (inisial) atau rekuren. Penentuan episode infeksi HG penting baik untuk tatalaksana maupun edukasi pasien.</p><p>Genital herpes is caused by Herpes simplex virus (HSV). Immunologic changes in pregnancy may increase susceptibility to HSV infection as one of the major cause of morbidity and mortality for both mother and fetus. The effect to the mother and fetus/ neonate depends on whether a primary infection (initial) or a recurrent infection. Determination of an episode of genital herpes is important to provide best management and education.</p><p> </p>
<p>Bedah sedot lemak pada area wajah metode tumescent local anesthesia (TLA) merupakan salah satu metode pilihan untuk menghilangkan lemak yang berlebih terutama pada area submental (double chin) dan lemak di daerah pipi bagian bawah atau yang menggantung di rahang. Bedah sedot lemak melalui TLA saat ini adalah metode pilihan utama karena memiliki standar keamanan tinggi, penyembuhan luka yang cepat, dan pasien tidak perlu rawat inap.</p><p>Liposuction surgery on the face area with the tumescent local anesthesia (TLA) method is one of the methods of choice to remove excess fat, especially in the submental area (double chin) and fat in the lower cheek area or hanging from the jaw. Liposuction surgery via TLA is currently the method of choice because it has high safety standards, fast wound healing, and does not require hospitalization.</p>
Background: Acne vulgaris is a skin disease that can cause permanent scarring. Various therapeutic options are available to treat atrophic scars, but combination therapy is still the best choice according to different types of scars in a single patient. Chemical reconstruction of skin scars (CROSS) trichloroacetic acid (TCA), modified subcutaneous incisionless (subcision), and platelet-rich plasma (PRP) can be used as a combination therapy to treat acne scars. Case Illustration: A 25-year-old man complained of acne scars on both sides of his face. Dermatologic findings were blackheads, icepick, boxcar, and rolling scars. Clinically he had moderate to severe acne scores. He was treated with a combination of CROSS TCA for icepick-type acne scars, modified subcision, and PRP injection for rolling and boxcar-type acne scars on both sides of the face. During treatment, the patient was given oral and topical antibiotics. The patient was followed-up after one month. It resulted in a good therapeutic response, which showed 25%-49% of Goodman and Baron’s classification, and a visual analog scale of 6. Discussion: CROSS TCA is a therapeutic choice for icepick-type acne scars with a simple, practical technique and provides a significant effect. Modified subcision is modified therapies from the previous Khunger subcision technique and a new alternative that can be applied to damaged tissue. This can maximally repair scarring, facilitate surgeon, provide avenues, and increase maximum PRP penetration. Conclusion: CROSS TCA with subcision and PRP are simple procedures that can be applied as an alternative therapy to acne scars with good therapeutic response. Keywords: CROSS TCA, PRP, scars, subcision
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.